TERT and hepatocellular carcinoma: The most frequently mutated gene in plasma was TERT promoter, with a frequency of 76.7% (23/30 patients), followed by TP53 mutated in 50% (15/30) of cfDNA samples, consistent with it being described in the previous literature about the mutational profile of early-stage HCC [7,33,34].